Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 2
Out of 5,090 analysts
134
Total ratings
67.02%
Success rate
163.39%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Hold | $117 | $102.68 | +13.95% | 1 | Dec 1, 2025 | |
| DGX Quest Diagnostics | Maintains: Buy | $200 → $215 | $184.18 | +16.73% | 3 | Oct 21, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $396.37 | -2.87% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $148.32 | +4.50% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $162.17 | -50.67% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $27.82 | +58.16% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,422.81 | -22.69% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $227.13 | +14.47% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $261.48 | +10.91% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $12.13 | +81.44% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $74.86 | +13.55% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $47.08 | +18.14% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $32.39 | +8.06% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $102.55 | +21.89% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $18.11 | +32.52% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.49 | +60.97% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.08 | +44.23% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $242.83 | -41.52% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $108.75 | -70.57% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $127.80 | -10.02% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $7.31 | +173.79% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $575.24 | +13.00% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $16.50 | -45.44% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.06 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.92 | +525.00% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $7.71 | +678.72% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $5.05 | +355.45% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $184.04 | +111.91% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.58 | +599.03% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $568.65 | -64.83% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $20.13 | +19.23% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $11.27 | +299.47% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $165.54 | -57.71% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $224.92 | -46.65% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.03 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $48.22 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $11.84 | +364.72% | 1 | Jul 19, 2016 |
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $102.68
Upside: +13.95%
Quest Diagnostics
Oct 21, 2025
Maintains: Buy
Price Target: $200 → $215
Current: $184.18
Upside: +16.73%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $396.37
Upside: -2.87%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $148.32
Upside: +4.50%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $162.17
Upside: -50.67%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $27.82
Upside: +58.16%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,422.81
Upside: -22.69%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $227.13
Upside: +14.47%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $261.48
Upside: +10.91%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $12.13
Upside: +81.44%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $74.86
Upside: +13.55%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $47.08
Upside: +18.14%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $32.39
Upside: +8.06%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $102.55
Upside: +21.89%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $18.11
Upside: +32.52%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $2.49
Upside: +60.97%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.08
Upside: +44.23%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $242.83
Upside: -41.52%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $108.75
Upside: -70.57%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $127.80
Upside: -10.02%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $7.31
Upside: +173.79%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $575.24
Upside: +13.00%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $16.50
Upside: -45.44%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.92
Upside: +525.00%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $7.71
Upside: +678.72%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $5.05
Upside: +355.45%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $184.04
Upside: +111.91%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.58
Upside: +599.03%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $568.65
Upside: -64.83%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $20.13
Upside: +19.23%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $11.27
Upside: +299.47%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $165.54
Upside: -57.71%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $224.92
Upside: -46.65%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.03
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $48.22
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $11.84
Upside: +364.72%